Vivimed Labs gallops after good Q1 outcome

Vivimed Labs jumped 9.02% to Rs 297.20 at 15:21 IST on BSE after consolidated net profit rose 41.1% to Rs 24.17 crore on 9.6% fall in net sales to Rs 331.53 crore in Q1 June 2015 over Q1 June 2014.

The company announced the Q1 result after market hours on Friday, 14 August 2015.

Meanwhile, the BSE Sensex was down 201.88 points, or 0.72%, to 27,865.43

On BSE, so far 2.15 lakh shares were traded in the counter, compared with an average volume of 44,479 shares in the past one quarter.

The stock hit a high of Rs 309.90 and a low of Rs 272.60 so far during the day. The stock hit a 52-week high of Rs 435.40 on 1 December 2014. The stock hit a 52-week low of Rs 175 on 24 June 2015.

The stock had outperformed the market over the past one month till 14 August 2015, rising 7.7% compared with a 0.48% rise for the Sensex. The scrip, however, underperformed the market in past one quarter, sliding 19.85% as against Sensex's 3.17% rise.

The small-cap company has an equity capital of Rs 16.20 crore. Face value per share is Rs 10.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News